610O Preliminary Results from a Phase I, First-in-human Study of DS-9606a, a Claudin 6 (Cldn6)-Directed Antibody-Drug Conjugate (ADC), in Patients (pts) with Tumor Types Known to Express CLDN6
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要